Cite
Royal Jelly Attenuates LPS-Induced Inflammation in BV-2 Microglial Cells through Modulating NF-κB and p38/JNK Signaling Pathways.
MLA
You, Meng-Meng, et al. “Royal Jelly Attenuates LPS-Induced Inflammation in BV-2 Microglial Cells through Modulating NF-ΚB and P38/JNK Signaling Pathways.” Mediators of Inflammation, Apr. 2018, pp. 1–11. EBSCOhost, https://doi.org/10.1155/2018/7834381.
APA
You, M.-M., Chen, Y.-F., Pan, Y.-M., Liu, Y.-C., Tu, J., Wang, K., & Hu, F.-L. (2018). Royal Jelly Attenuates LPS-Induced Inflammation in BV-2 Microglial Cells through Modulating NF-κB and p38/JNK Signaling Pathways. Mediators of Inflammation, 1–11. https://doi.org/10.1155/2018/7834381
Chicago
You, Meng-Meng, Yi-Fan Chen, Yong-Ming Pan, Yi-Chen Liu, Jue Tu, Kai Wang, and Fu-Liang Hu. 2018. “Royal Jelly Attenuates LPS-Induced Inflammation in BV-2 Microglial Cells through Modulating NF-ΚB and P38/JNK Signaling Pathways.” Mediators of Inflammation, April, 1–11. doi:10.1155/2018/7834381.